Clinical and physical quality assurance for intensity modulated radiotherapy of prostate cancer

Radiotherapy and Oncology

Volumn 71, Issue 3, 2004, Pages 319-325

  Boehmer, Dirk ^a   Bohsung, Joerg ^a   Eichwurzel, Ines ^a   Moys, Anne ^a   Budach, Volker ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Intensity modulated radiotherapy; Prostate cancer; Quality assurance; Radiotherapy

Indexed keywords

CANCER PATIENT; CANCER RADIOTHERAPY; HEALTH PHYSICS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MEDICAL LITERATURE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; RADIATION PHYSICS; REVIEW;

EID: 2542471344     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2004.02.016     Document Type: Article

References (41)

1. Alasti H., Petric M.P., Catton C.N., Warde P.R. Portal imaging for evaluation of daily on-line set-up errors and off-line organ motion during conformal irradiation of carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 49:2001;869-884
2. Antolak J.A., Rosen I.I., Childress C.H., Zagars G.K., Pollack A. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys. 42:1998;661-672
3. Bakai A., Paulsen F., Plasswilm L., Bamberg M., Nüsslin F. Positioning accuracy in conformational prostatic irradiation using portal imaging. Strahlenther Onkol. 178:2002;84-90
4. Bedford J.L., Khoo V.S., Oldham M., Dearnaley D.P., Webb S. A comparison of coplanar four-field techniques for conformal radiotherapy of the prostate. Radiother Oncol. 51:1999;225-235
5. Bey P., Carrie C., Beckendorf V., et al. Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer - preliminary results. Int J Radiat Oncol Biol Phys. 48:2000;513-517
6. Brenner D.J., Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 43:1999;1095-1101
7. Brenner D.J., Martinez A.A., Edmundson G.K., Mitchell C., Thames H.D., Armour E.P. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys. 52:2002;6-13
8. Butler E.B., Teh B.S., Grant W.H. 3rd, et al. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys. 45:1999;21-32
9. Catton C., Haycocks T., Alasti H., et al. Portal film analysis of as escalated dose conformal prostatic irradiation protocol using fiducial markers and portal images to confirm target organ and isocentre position (Abstr.). Int J Radiat Oncol Biol Phys. 42:1998;216
10. Chui C.S., Spirou S., LoSasso T. Testing of dynamic multileaf collimation. Med Phys. 23:1996;635
11. Chun M., Timmerman R.D., Mayer R., Ling M.N., Sheldon J., Fishman E.K. Radiation therapy of external iliac lymph nodes with lateral pelvic portals: identification of patients at risk for inadequate regional coverage. Radiology. 194:1995;147-150
12. Dawson L.A., Litzenberg D.W., Brock K.K., et al. A comparison of ventilatory prostate movement in four treatment positions. Int J Radiat Oncol Biol Phys. 48:2000;319-323
13. De Brabandere M., Van Esch A., Kutcher G.J., Huyskens D. Quality assurance in intensity modulated radiotherapy by identifying standards and patterns in treatment preparation: a feasibility study on prostate treatments. Radiother Oncol. 62:2002;283-291
14. Depuydt T., Van Esch A., Huyskens D. A quantitative evaluation of IMRT dose distributions: refinement and clinical assessment of the gamma evaluation. Radiother Oncol. 62:2002;309-319
15. Fowler J., Chappell R., Ritter M. Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys. 50:2001;1021-1031
16. Hanks G.E., Hanlon A.L., Pinover W.H., Horwitz E.M., Price R.A., Schultheiss T. Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys. 46:2000;823-832
17. Huang E., Dong L., Chandra A., et al. Intrafraction prostate motion during IMRT for prostate cancer. Int J Radiat Oncol Biol Phys. 53:2002;261-268
18. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy. ICRU Report 50. 1993;ICRU, Bethesda, MD
19. King C.R. What is the Tpot for prostate cancer? Radiobiological implications of the equivalent outcome with 125I or 103Pd. Int J Radiat Oncol Biol Phys. 47:2000;1165-1167
20. King C.R., Fowler J.F. A simple analytic derivation suggests that prostate cancer a/b ratio is low. Int J Radiat Oncol Biol Phys. 51:2001;213-214
21. Kitamura K., Shirato H., Seppenwoolde Y., et al. Three-dimensional intrafractional movement of prostate measured during real-time tumor tracking radiotherapy in supine and prone treatment positions. Int J Radiat Oncol Biol Phys. 53:2002;1117-1123
22. Ling C.C., Burman C., Chui C.S., et al. Conformal radiation treatment of prostate cancer using inversely planned intensity modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys. 35:1996;721-730
23. Litzenberg D., Dawson L.A., Sandler H., et al. Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys. 52:2002;699-703
24. Low D.A., Harms W.B., Mutic S., Purdy J.A. A technique for the quantitative evaluation of dose distributions. Med Phys. 25:1998;656
25. Lyons J.A., Kupelian P.A., Mohan D.S., Reddy C.A., Klein E.A. Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate. J Urol. 55:2000;1185-1190
26. Melian E., Mageras G.S., Fuks Z., et al. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int J Radiat Oncol Biol Phys. 38:1997;73-81
27. Nederveen A.J., van der Heide U.A., Dehnad H., Van Moorselaar R.J., Hofman P., Lagendijk J.J.D. Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int J Radiat Oncol Biol Phys. 53:2002;206-214
28. Pang G., Beachey D.J., O'Brien P.F., Rowlands J.A. Imaging of 1.0 mm-diameter radiopaque markers with megavoltage X-rays: an improved online imaging system. Int J Radiat Oncol Biol Phys. 52:2002;532-537
29. Perez C.A., Michalsky J.M., Purdy J.A., Wasserman T.H., Williams K., Lockett M.A. Three dimensional conformal therapy or standard irradiation in localized carcinoma of prostate: preliminary results of a nonrandomized comparison. Int J Radiat Oncol Biol Phys. 47:2000;629-637
30. Sandhu A.S., Zelefsky M.J., Lee H.J., Lombardi D., Fuks Z., Leibel S.A. Long term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection. Int J Radiat Oncol Biol Phys. 48:2000;643-647
31. Schwarz M., Bos L.J., Mijnheer B.J., Lebesque J.V., Damen E.M.F. Importance of accurate dose calculations outside segment edges in intensity modulated radiotherapy treatment planning. Radiother Oncol. 69:2003;305-314
32. Skwarchuk M.W., Jackson A., Zelefsky M.J., et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys. 47:2000;103-113
33. Song P.Y., Washington M., Vaida F., et al. A comparison of four patient immobilization devices in the treatment of prostate cancer patients with three dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 34:1996;213-219
34. Storey M.R., Pollack A., Zagars G., Smith L., Antolak J., Rosen I. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of randomized trial. Int J Radiat Oncol Biol Phys. 48:2000;635-642
35. Tinger A., Michalski J.M., Cheng A., et al. A critical evaluation of the planning target volume for 3D conformal radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 42:1998;213-221
36. Trotti A., Byhardt R., Stetz J., et al. Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys. 47:2000;13-47
37. Van Esch A., Bohsung J., Sorvari P., et al. Acceptance tests and quality control (QC) procedures for the clinical implementation of intensity modulated radiotherapy (IMRT) using inverse planning and the sliding window technique: experience from five radiotherapy departments. Radiother Oncol. 65:2002;53-70
38. van Lin E.N., Nijenhuis E., Huizenga H., van der Vight L., Visser A. Effectiveness of couch height-based patient set-up and an off-line correction protocol in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys. 50:2001;569-577
39. Wachter S., Gerstner N., Dorner D., et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 52:2002;91-100
40. Zelefsky M.J., Cowen D., Fuks Z. Long Term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer. 85:1999;2460-2468
41. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 53:2002;1111-1116